Results 131 to 140 of about 1,334 (146)
Some of the next articles are maybe not open access.
Association of Occlusive Retinal Vasculitis With Intravitreal Faricimab
JAMA OphthalmologyThis case report describes a patient with attenuation of retinal arterioles and veins associated with 2 blot hemorrhages and pallor of the inferotemporal retina without emboli.
Ye, Li, Robert, Chong, Adrian T, Fung
openaire +2 more sources
Vitritis following intravitreal faricimab: a retrospective monocentric analysis
Graefe's Archive for Clinical and Experimental OphthalmologyIntravitreal injections of anti-VEGF agents are considered as safe, with a very low rate of intraocular inflammations (IOI). Faricimab is a novel intravitreal bispecific antibody targeting both VEGF-A and angiopoietin-Tie2 independently. Despite a safe profile in randomized clinical trials, several real-life studies have reported cases of IOI.
Alexandre Bourdin +6 more
openaire +2 more sources
INTRAOCULAR INFLAMMATION ASSOCIATED WITH FARICIMAB THERAPY
RetinaPurpose: To report 1-year real-world evidence on intraocular inflammation (IOI) adverse events in patients undergoing faricimab therapy in a tertiary care hospital. Methods: A retrospective review of electronic medical records was conducted for patients receiving faricimab treatment
Andrea Montesel +9 more
openaire +2 more sources
From Bench to Bedside: Faricimab Enters the Clinic
Ophthalmic Surgery, Lasers and Imaging Retina, 2022Cecilia Villanueva, Boone +2 more
openaire +2 more sources
Retinal Vasculitis after Intravitreal Faricimab Injection
Ophthalmology RetinaTang-An Hsiao +2 more
openaire +1 more source